CDKN1C and neoplasm: Inhibition of the activity of the aromatase enzyme, cyclin D1, CDK4, Bcl-xL, and pS2, while increasing the expression of CCAAT/C/EBP, pERK-1&-2, and p57Kip2 that results in decrease the tumour growth.